Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Sheng-Chen Wen is a pioneering urologic surgeon whose research centers on advancing minimally invasive surgical techniques for urologic cancers, particularly renal and prostate malignancies. His major contributions lie in refining single-site and robotic-assisted procedures to reduce patient morbidity while maintaining oncologic efficacy. Notably, his 2020 work on single-site sutureless partial nephrectomy for small exophytic renal tumors (13 citations) introduced a streamlined approach that eliminates the steep learning curve associated with traditional laparoscopic partial nephrectomy, potentially expanding access to nephron-sparing surgery. In 2021, he advanced the field with a study on extraperitoneal robotic laparo-endoscopic single-site plus1-port radical prostatectomy using the da Vinci Single-Site platform (8 citations), addressing aesthetic and morbidity concerns while navigating the limitations of the SP system. His 2023 cumulative sum analysis of the learning curve for single-site robot-assisted radical prostatectomy (2 citations) provides crucial benchmarks for surgeons adopting this technique. Additionally, his 2025 investigation into adjuvant therapy for biochemical recurrence in prostate cancer patients with positive surgical margins (3 citations) offers valuable clinical insights. Dr. Wen’s work consistently bridges surgical innovation with practical implementation, making him a notable figure in the evolution of scarless urologic oncology.